James M Daly insider trades: Acadia Pharmaceuticals (ACAD) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where James reports to the SEC
and 1 more company
Open-market buys and sales
23 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 10, 2025 | ACAD | ↓ Sell | 30,000 | $22.37 | $671K | Direct | Nov 12, 2025 (2d) |
| Feb 27, 2025 | MDGL | ↓ Sell | 15,470 | $347.45 | $5.4M | Direct | Feb 28, 2025 (1d) |
| Apr 2, 2024 | MDGL | ↓ Sell | 32,489 | $252.97 | $8.2M | Direct | Apr 3, 2024 (1d) |
| Aug 14, 2023 | HALO | ↓ Sell | 20,000 | $43.73 | $875K | Direct | Aug 15, 2023 (1d) |
| Nov 25, 2020 | HALO | ↓ Sell | 10,363 | $40.41 | $419K | Direct | Nov 25, 2020 (0d) |
| Aug 13, 2020 | HALO | ↓ Sell | 34,337 | $29.12 | $1000K | Direct | Aug 13, 2020 (0d) |
| May 11, 2020 | ACAD | ↓ Sell | 26,250 | $51.13 | $1.3M | Direct | May 13, 2020 (2d) |
| Sep 9, 2019 | ACAD | ↓ Sell | 30,000 | $37.80 | $1.1M | Direct | Sep 11, 2019 (2d) |
| Jun 23, 2015 | INCY | ↓ Sell10b5-1 | 11,691 | $108.24 | $1.3M | Direct | Jun 25, 2015 (2d) |
| May 26, 2015 | INCY | ↓ Sell10b5-1 | 12,093 | $106.40 | $1.3M | Direct | May 28, 2015 (2d) |
| Apr 23, 2015 | INCY | ↓ Sell10b5-1 | 36,941 | $107.67 | $4.0M | Direct | Apr 24, 2015 (1d) |
| Feb 24, 2015 | INCY | ↓ Sell10b5-1 | 11,112 | $82.19 | $913K | Direct | Feb 25, 2015 (1d) |
| Jan 23, 2015 | INCY | ↓ Sell10b5-1 | 11,109 | $77.68 | $863K | Direct | Jan 26, 2015 (3d) |
| Dec 23, 2014 | INCY | ↓ Sell10b5-1 | 11,113 | $74.43 | $827K | Direct | Dec 29, 2014 (6d) |
| Nov 24, 2014 | INCY | ↓ Sell10b5-1 | 11,111 | $74.08 | $823K | Direct | Nov 26, 2014 (2d) |
| Oct 23, 2014 | INCY | ↓ Sell10b5-1 | 11,111 | $53.49 | $594K | Direct | Oct 24, 2014 (1d) |
| Sep 23, 2014 | INCY | ↓ Sell10b5-1 | 11,111 | $47.65 | $529K | Direct | Sep 25, 2014 (2d) |
| Aug 25, 2014 | INCY | ↓ Sell10b5-1 | 11,111 | $51.96 | $577K | Direct | Aug 27, 2014 (2d) |
| Jul 23, 2014 | INCY | ↓ Sell10b5-1 | 11,111 | $48.54 | $539K | Direct | Jul 25, 2014 (2d) |
| Jun 23, 2014 | INCY | ↓ Sell10b5-1 | 11,111 | $56.03 | $623K | Direct | Jun 25, 2014 (2d) |
| May 23, 2014 | INCY | ↓ Sell10b5-1 | 11,111 | $48.48 | $539K | Direct | May 28, 2014 (5d) |
| Apr 23, 2014 | INCY | ↓ Sell10b5-1 | 30,555 | $47.71 | $1.5M | Direct | Apr 25, 2014 (2d) |
| Feb 13, 2014 | INCY | ↓ Sell | 158,331 | $66.49 | $10.5M | Direct | Feb 18, 2014 (5d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ACAD insiders
Open-market trades in the last 12 months
About James M Daly's insider trades
James M Daly is an insider at Acadia Pharmaceuticals (ACAD). Since Feb 13, 2014, James has reported no open-market purchases and 23 sales worth $44.4M on SEC Form 4. In the last 12 months: 1 sale ($671K).
14 sales (33% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (55 filings), option exercises (25 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ACAD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.